Clinical trial · Observational
A Drug Utilization Study of Radium-223 in Sweden
A Drug Utilization Study of Xofigo Use in Sweden
NCT02331303CI-TRIAL-00031294completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of this study is to evaluate the extent of potential off-label use of Xofigo in Sweden.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Radium-223 dichloride (Xofigo, BAY88-8223) | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Group1
- description
- This is a single-arm descriptive observational drug utilization study based on secondary data collection of patients treated with Xofigo in Sweden. This study will include patients receiving treatment of Xofigo at certified nuclear medicine centers across Sweden during a two year period.
- interventionNames
- Other: Radium-223 dichloride (Xofigo, BAY88-8223)
Primary outcomes (6)
- measure
- Proportion of men with metastatic castration resistant prostate cancer (mCRPC) of Xofigo use
- timeFrame
- Up to 2 years
- measure
- Proportion of being women of Xofigo use
- timeFrame
- Up to 2 years
- measure
- Proportion of being children of Xofigo use
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients receiving Xofigo with data recorded at nuclear medicine centers in Sweden between 01 July 2014 and 30 June 2016 will be included in the study Exclusion Criteria: * Patients receiving Xofigo in a clinical trial will not be included in this study
References
Publications (0)
Data not yet available
No reference posted for this study.